Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bivalirudin (angiomax) (1 trial)
heparin (liquaemin) (1 trial)
Acute Coronary Syndrome (Phase 3)
Syndrome (Phase 3)
Trials (1 total)
Trial APIs (2 total)